Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Festou

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|May 11, 2026
[Infections in the elderly: what's new in 2026?]Benjamin Festou, Gaëtan Gavazzi
Infectious Diseases Now|May 15, 2026
Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet)Benjamin Festou, Achille Tchalla
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2023
Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)Guillaume Beraud, Laura Bouetard, Rok Civljak, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|May 11, 2026
[Infections in the elderly: what's new in 2026?]Benjamin Festou, Gaëtan Gavazzi
Infectious Diseases Now|May 15, 2026
Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet)Benjamin Festou, Achille Tchalla
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 1, 2023
Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)Guillaume Beraud, Laura Bouetard, Rok Civljak, et al.
Pageof 1